Oncology
Oncology
Plant compounds and gut microbiota activity influence how cancer drugs work and should be considered in treatment.
Oncology, Gastroenterology
Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.
Oncology
Genetic factors can influence tumor-associated microbes, offering insights into colorectal cancer progression and potential therapeutic targets.
Oncology
Certain bile acids produced by gut microbes can interact with specific receptors in the body, influencing immune cells to fight tumors.
Oncology, Gastroenterology
Each Fusobacterium nucleatum population has unique traits and distribution patterns across body sites and conditions such as colorectal cancer and Crohn’s disease.
Oncology
The microbiota plays a protective role against colorectal cancer by regulating Snhg9.
Oncology
Probiotics such as Lactobacillus can complement breast cancer therapy to improve prevention and treatment.
Oncology
The presence of specific microbes in the gut microbiota can serve as biomarkers for predicting the efficacy of immunotherapy.
Oncology
Specific gut microbiota features correlate with better responses to immunotherapy in people with melanoma.
Industry, Oncology
The study revealed that MS-20 dramatically improved treatment outcomes, tripling the objective response rate (ORR) to 75% when combined with Keytruda.